4.3 Article

Adapting Shared Decision Making for Individuals With Severe Mental Illness

Journal

PSYCHIATRIC SERVICES
Volume 65, Issue 12, Pages 1483-1486

Publisher

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ps.201400307

Keywords

-

Funding

  1. Janssen-Cilag
  2. Lilly
  3. Otsuka
  4. AstraZeneca
  5. Bristol-Myers Squibb
  6. Eli Lilly
  7. Janssen
  8. Johnson and Johnson
  9. Lundbeck
  10. Merck
  11. Novartis
  12. Organon
  13. Pfizer
  14. Pierre Fabre
  15. Roche
  16. Sanofi-Aventis
  17. Servier

Ask authors/readers for more resources

Shared decision making has found its way into mental health care to a limited extent only, and especially challenging patients do not benefit from this approach. The authors describe barriers to shared decision making among mental health professionals and among patients. They propose an integrative approach-SDM-PLUS that fosters shared decision making in mental health settings. SDM-PLUS empowers both patients and mental health care providers. Patients are empowered to become more active and self-confident and to acquire greater skills in regard to health literacy and communication. Providers are trained in analyzing decisional situations and are empowered to use a wider array of communication strategies to optimize patient participation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available